Our Location | Contact Us | Careers

TGaS® Advisors provides pharmaceutical companies with tools for continuous improvement, and with fact-based answers to the question: “How do other pharmaceutical companies do ‘it’?”®


Press Release

Managed Markets Leaders Identify Most Urgent Concerns

TGaS® Advisors Finds Aligning Resources to Customers is Key


East Norriton, Penn., Sept. 21, 2009 – Managed Markets leaders ranked activities that optimize business relationships with customers as their most urgent concern for the future. A TGaS® Advisors White Paper, “The Future of Managed Markets: Aligning Resources to Customers”, details these concerns, based on recent studies conducted by the pharmaceutical industry benchmarking and advisory firm.

Over half the respondents, Managed Markets executives in 15 of the top pharmaceutical companies, showed the greatest concern for predicting contract value. Benchmark data show that this area depends more on the people making the decisions than on standard processes and procedures. Other areas ranking high on the list are pull-through, analysis and reporting and Account Manager skill development.

The White Paper also includes information on other challenges, such as how Managed Markets leaders are preparing for healthcare reform initiatives.
Brian Bamberger, Vice President, Management Advisor and TGaS Advisors Managed Markets Practice Leader, said, “Industry pressure to develop new commercial models continues to grow, yet basic activities in Managed Markets areas are still not routine for companies. Rethinking how Managed Markets fits into these new commercial models and how it will meet the profitability needs posed by impending government and other changes is necessary to navigate these waters successfully.”

About TGaS® Advisors

TGaS Advisors, ranked in the top 50 among U.S. Business Products & Services companies by the Inc. 500, is the leader in benchmarking and advisory services to the pharmaceutical and biopharmaceutical industry. The TGaS Advisors roster includes nine of the top 10 and the majority of the top 50 pharmaceutical companies with operations in the U.S. market. The firm’s benchmarking and advisory services suite of solutions, PharmaStance®, provides clients with a way to measure where they stand with respect to their organizations and answers the question, “How do other pharmaceutical companies do ‘it’?”® TGaS Advisors is based in East Norriton, Pennsylvania.

Other 2009:
TGaS Advisors’ Gerard Featured on Executive Leaders Radio
TGaS Advisors Hosts Pharma Commercial Operations Summit on 2010 Trends
TGaS Advisors’ Donna Wray Invited to Present Benchmark Findings and Recommendations on Digital Marketing Issues at DDMAC Hearings
The Right Skill Sets for Pharma More Critical Than Ever in 2009, According to TGaS Advisors Organizational Career Guide
TGaS Advisors Sample Accountability Benchmark Shows Stepped-Up Focus on Compliance Operations
TGaS Advisors Named to Philadelphia 100®
Brian Deppen Joins TGaS Advisors Managed Markets Practice
TGaS Advisors Appoints Anthony Sorce, Vice President, New Business Development and Jeff Wojcik Promoted to Principal
TGaS Advisors Named to 2009 INC 500/5000, Ranked First in Business Products & Services in the Mid-Atlantic Region
Commercial Compliance Benchmark Charts Promotional Monitoring by Pharmaceutical Companies
Critical Job Skills, Career Progression are Key Issues for Sales Ops Leadership
Taking “Closed Loop” to the Next Level: Re-Imagining Sales and Managed Markets as an Interactive System
TGaS Advisors Convenes “Mega-Summit” for Pharma Leaders on the Impact of Industry Trends on Commercial Organizations
FDA Letters Hobble a Favorite Relationship Marketing Tactic of TGaS Advisors Benchmark Companies Page
TGaS Advisors Analytics Experts Urge Pharma Management Sciences Professionals to Help Shape Industry Future
TGaS Advisors Appoints Curt Staab Director, Management Advisor, Sales Advisory Practice
TGaS Advisors Offers Benchmark-based Services to Support Integration Following Recent Wave of Mergers & Acquisitions
TGaS Advisors Introduces Commercial Compliance Benchmark